Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$240M |
| 2 |
eBay
EBAY
|
+$231M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$216M |
| 4 |
Ameren
AEE
|
+$196M |
| 5 |
Kohl's
KSS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$552M |
| 2 |
Micron Technology
MU
|
+$425M |
| 3 |
Visa
V
|
+$225M |
| 4 |
Marathon Petroleum
MPC
|
+$225M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.17% |
| 2 | Healthcare | 12.72% |
| 3 | Technology | 12.27% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 11.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HDV
2701
iShares Core High Dividend ETF
HDV
$15.4B
| $935K | ﹤0.01% |
55,340
-9,445
| -15% | -$167K |
|
2702
Sonic Automotive
SAH
$2.43B
| $933K | ﹤0.01% |
49,256
-43,619
| -47% | -$880K |
|
2703
Celsius Holdings
CELH
$8.94B
| $932K | ﹤0.01% |
642,786
+382,164
| +147% | +$675K |
|
2704
Goldgroup Mining
GORO
$292M
| $932K | ﹤0.01% |
206,743
+55,484
| +37% | +$250K |
|
|
ZEUS
2705
DELISTED
Olympic Steel
ZEUS
| $930K | ﹤0.01% |
+45,343
| New | +$1.03M |
|
2706
Donaldson
DCI
$10.8B
| $928K | ﹤0.01% |
20,604
-589,749
| -97% | -$28.2M |
|
2707
iShares Mortgage Real Estate ETF
REM
$541M
| $928K | ﹤0.01% |
+21,834
| New | +$929K |
|
|
ISEE
2708
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $928K | ﹤0.01% |
338,512
-669,378
| -66% | -$1.94M |
|
2709
Cohen & Steers REIT and Preferred and Income Fund
RNP
$982M
| $927K | ﹤0.01% |
49,575
+32,708
| +194% | +$625K |
|
2710
Gildan
GIL
$10.1B
| $926K | ﹤0.01% |
32,036
+14,506
| +83% | +$449K |
|
|
MDSO
2711
DELISTED
Medidata Solutions, Inc.
MDSO
| $923K | ﹤0.01% |
14,697
-24,235
| -62% | -$1.61M |
|
|
SGYP
2712
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $923K | ﹤0.01% |
504,383
+485,558
| +2,579% | +$1.03M |
|
2713
Southwest Airlines
LUV
$20B
| $920K | ﹤0.01% |
16,064
-1,326,354
| -99% | -$79.7M |
|
|
STML
2714
DELISTED
Stemline Therapeutics, Inc.
STML
| $919K | ﹤0.01% |
60,056
-229,949
| -79% | -$3.58M |
|
2715
Hovnanian Enterprises
HOV
$747M
| $918K | ﹤0.01% |
20,056
+16,374
| +445% | +$944K |
|
2716
Ituran Location and Control
ITRN
$1.01B
| $918K | ﹤0.01% |
29,519
-8,832
| -23% | -$304K |
|
|
FSNN
2717
DELISTED
Fusion Connect, Inc. Common Stock
FSNN
| $917K | ﹤0.01% |
189,220
+172,866
| +1,057% | +$838K |
|
2718
BlackRock Enhanced Global Dividend Trust
BOE
$694M
| $915K | ﹤0.01% |
79,127
+60,741
| +330% | +$743K |
|
|
IMMU
2719
PUT
DELISTED
Immunomedics Inc
IMMU
| $915K | ﹤0.01% |
62,600
-37,400
| -37% | -$611K |
|
|
PTLA
2720
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $913K | ﹤0.01% |
27,959
+17,658
| +171% | +$775K |
|
2721
Primis Financial Corp
FRST
$398M
| $912K | ﹤0.01% |
+57,573
| New | +$924K |
|
|
CURO
2722
DELISTED
CURO Group Holdings Corp.
CURO
| $912K | ﹤0.01% |
52,996
-63,089
| -54% | -$1.05M |
|
|
TBHC
2723
DELISTED
The Brand House Collective
TBHC
| $911K | ﹤0.01% |
94,030
-62,429
| -40% | -$655K |
|
2724
MakeMyTrip
MMYT
$5.68B
| $910K | ﹤0.01% |
+26,229
| New | +$835K |
|
2725
CALL
Axalta
AXTA
$7.79B
| $906K | ﹤0.01% |
+30,000
| New | +$938K |
|
Similar funds
Israel Englander's Q1 2018 Portfolio in Review
As of Q1 2018, Israel Englander held 4,417 positions worth $74.9B, up 3.4% from $72.5B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Israel Englander deployed $3.29B of net new capital in Q1 2018, opening 664 new positions and adding to 1,466 existing holdings. Its largest new stake was Tiffany & Co.: 1,078,847 shares worth $105M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $552M trimmed.
- Israel Englander's largest Q1 2018 buy was Tiffany & Co.: 1,078,847 shares worth $105M.
- Israel Englander added most to Boston Scientific in Q1 2018, an estimated $240M increase.
- Israel Englander's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $552M.
- Israel Englander fully exited Equinix in Q1 2018, selling an estimated $152M.
- Israel Englander's ten largest holdings make up 6.3% of its $74.9B portfolio in Q1 2018.
- Israel Englander opened 664 new positions and closed 833 in Q1 2018.
- Israel Englander's portfolio value rose 3.4% quarter-over-quarter to $74.9B.
Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.